Full Text (PDF)
Original Article

Comparison between Intracervical Misoprostol (200mcg) and EXTRA Amniotic 20% Mannitol (100ml) + Carbeprost (250 mcg) in Second Trimester Abortions Upto 20 WK

Arun Gupta, Professor & Head, Dept. of Obstetrics and Gynaecology, Geetanjali Hospital, Near Eklingpura Chauraha, NH8, Manwa Kheda, Udaipur, Rajasthan313001, India. , Arun Gupta* , Aishwarya Sinha** , Kanishk Nayak**

Author Information

Licence:




Indian Journal of Obstetrics and Gynecology 5(2):p 25-28, April - June 2017. | DOI: http://dx.doi.org/10.21088/ijog.2321.1636.5217.4

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Objectivewe aim to evaluate another safe method for second trimester abortions upto 20wk of gestation. Methods: this is a prospective study of 40 patients undergoing termination of pregnancy upto 20 wk in Geetanjali medical college & Hospital. Detail history of patient was obtained and study carried out after consent of the patient. Result: To induce termination of pregnancy, during 1120 weeks of gestation, extra amniotic 20% mannitol solution (100ml) + carbeprost (250) was used in 20 patients. The amount of mannitol was 100 cc through foleys catheter. Where as other 20 patients were induced with vaginal misoprostol 200 mg repeated 46 hrly. Mean abortion time with mannitol was 31.55 hour, with no side effects were noted. The longest induction abortion interval was 45 hours and 80% with in 30 hours and 100 % delivered with in 36 hours.

Kerywords: Intracervical Misoprostol; Mannitol; Amniotic 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijog.2321.1636.5217.4

Keywords


Article Level Metrics

Last Updated

Tuesday 08 September 2026, 18:08:08 (IST)


3506

Accesses

5
580
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share